flowchart LR
    CDC["CDC"] -->|recommends| Twodose_series["Two-dose series"]
    Recombinant_Herpes_Zoster_Vaccine["Recombinant Herpes Zoster Vaccine"] -->|is effective in| Adults_aged_65_years_or_older["Adults aged 65 years or older"]
    Recombinant_Herpes_Zoster_Vaccine["Recombinant Herpes Zoster Vaccine"] -->|is effective in| Immunocompromised_individuals["Immunocompromised individuals"]
    Recombinant_Herpes_Zoster_Vaccine["Recombinant Herpes Zoster Vaccine"] -->|is effective in| Immunocompetent_individuals["Immunocompetent individuals"]
    Twodose_series["Two-dose series"] -->|increases effectiveness against| Shingles["Shingles"]
    Twodose_series["Two-dose series"] -->|increases effectiveness against| Postherpetic_Neuralgia["Postherpetic Neuralgia"]
    Twodose_series["Two-dose series"] -->|increases effectiveness against| Ophthalmicus["Ophthalmicus"]
    Adults_aged_85_years_or_older["Adults aged 85 years or older"] -->|is lower in| Vaccine_effectiveness_VE["Vaccine effectiveness (VE)"]
    Vaccine_effectiveness_VE["Vaccine effectiveness (VE)"] -->|is lower in| Black_individuals["Black individuals"]
    Vaccine_effectiveness_VE["Vaccine effectiveness (VE)"] -->|is similar in| Immunocompromised_individuals["Immunocompromised individuals"]
    Vaccine_effectiveness_VE["Vaccine effectiveness (VE)"] -->|is similar in| Immunocompetent_individuals["Immunocompetent individuals"]
    Nadja_A_Vielot_PhD["Nadja A. Vielot, PhD"] -->|affiliated with| University_of_North_Carolina_School_of_Medicine["University of North Carolina School of Medicine"]
    Shirin_Mazumder_MD["Shirin Mazumder, MD"] -->|affiliated with| University_of_Tennessee_Health_Science_Center["University of Tennessee Health Science Center"]
    Study["Study"] -->|published in| Annals_of_Internal_Medicine["Annals of Internal Medicine"]
    Study["Study"] -->|supported by| National_Center_for_Advancing_Translational_Scienc["National Center for Advancing Translational Science"]
    Study_population["Study population"] -->|drawn from| Medicare["Medicare"]
    Vaccination_barriers["Vaccination barriers"] -->|include| Adverse_events["Adverse events"]
    Vaccination_barriers["Vaccination barriers"] -->|include| Financial_burden["Financial burden"]
    Reminder_systems["Reminder systems"] -->|proposed to overcome| Vaccination_barriers["Vaccination barriers"]
    Vaccine_programs["Vaccine programs"] -->|reduce| Financial_burden["Financial burden"]
    Recombinant_Herpes_Zoster_Vaccine["Recombinant Herpes Zoster Vaccine"] -->|associated with lower risk of| Dementia["Dementia"]
    IBD["IBD"] -->|associated with higher risk for| Shingles["Shingles"]
    IBD["IBD"] -->|associated with higher risk for| Postherpetic_Neuralgia["Postherpetic Neuralgia"]
    IBD["IBD"] -->|associated with higher risk for| Ophthalmicus["Ophthalmicus"]
    Live_Zoster_Vaccine["Live Zoster Vaccine"] -->|previously received by| Adults_aged_65_years_or_older["Adults aged 65 years or older"]
    Acyclovir["Acyclovir"] -->|used for| Herpes_Zoster_Oticus["Herpes Zoster Oticus"]
    Valacyclovir["Valacyclovir"] -->|used for| Herpes_Zoster_Oticus["Herpes Zoster Oticus"]